Chronic rapamycin treatment causes glucose intolerance and hyperlipidemia by upregulating hepatic gluconeogenesis and impairing lipid deposition in adipose tissue.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples